ArticleOncoTargets and therapy2019

EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells.

Anna Hester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.